Dimethyl Fumarate in Adrenomyeloneuropathy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dimethyl Fumarate in Adrenomyeloneuropathy — Stella

Home/Adrenomyeloneuropathy Without Cerebral Involvement/

View on ClinicalTrials.gov

Recruiting

Back to Adrenomyeloneuropathy Without Cerebral Involvement trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

Spain

Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona

Donostia University Hospital, Donostia / San Sebastian

University Hospital 12 de Octubre, Madrid

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Pujol, Aurora, M.D.

Collaborators

Instituto de Salud Carlos III, Spanish Clinical Research Network - SCReN

Enrollment target

~40 participants

Started

April 2024

Primary completion

March 2028

Age range

18 Years – 65 Years

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.